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The use of piecewise exponential distributions was proposed by Rai et al. (2013) for 
analyzing cardiotoxicity data. Some parametric models are proposed, but the focus is on 
the Weibull distribution, which overcomes the limitation of piecewise exponential. 
 
Keywords: Current status data, change point, constant hazard rate, Weibull 
distribution, phase IV clinical trial 
 
Introduction 
With significant advancements in cancer treatment an increasing number of cancer 
survivors are living many years following a successful treatment. About a decade 
ago it was estimated nearly 13 million Americans were cancer survivors and over 
379,000 were survivors of childhood and adolescent cancers (Mariotto et al., 2009). 
With this encouraging success comes the realization that survivors are at an 
increased risk of late adverse effects and of late mortality many years following 
cancer treatment. As described in Chow and Liu (2004), phase IV clinical trials are 
often used to document such long-term safety, toxicity, and mortality in cancer 
survivors. 
Armstrong et al. (2009) showed cardiovascular events are the leading non-
malignant cause of death among childhood cancer survivors with a 7-fold higher 
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risk of cardiovascular mortality compared to age-matched controls. Both 
chemotherapy and radiation therapy are known to be toxic to cardiomyocytes and 
contribute to early mortality. One such chemotherapy agent anthracycline is known 
to be cardiotoxic (Hudson et al., 2007), but because of its therapeutic benefits it 
remains one of the key components of the treatment plan. Often, in long-term 
follow-up studies the interest is not only on estimating the mortality but also on 
estimating the cumulative incidence of certain types of events, e.g. the onset of 
cardiotoxicity. With long-term follow-up studies it is common to see that the data 
from the survivor were not collected continuously in real time but at regular 
intervals (e.g., every six months or every year). The onset times for the events of 
interest are unknown, but the current status of each participant is known, such as 
whether the event of interest occurred in between the observation periods or not. 
This was characterized as case I interval censored data (Sun, 2006; Rai, 2008). 
Based on these data the prevalence of toxicity can be estimated, although the 
incidence rate is not straightforward. 
The use of nonparametric methods for interval-censored data was discussed, 
for example, by Sun (2006), but the development of a parametric approach has 
lagged behind. Within the framework of parametric modeling and using likelihood 
theory one can easily use any one of the parametric models such as Exponential, 
Weibull, Log-normal, Gamma, Generalized Gamma, Log-logistic, and Generalized 
F, proposed in Kalbfleisch and Prentice (2002). Several more parametric 
distributions, such as the hypertabastic distribution proposed by Tabatabai, Bursac, 
Williams, and Singh (2007) or the generalized log-logistic proposed by Singh and 
Bartolucci (1997), were proposed for modeling survival data. However, the 
intensity functions for many of these distributions are not available in a nice closed 
form and may involve incomplete gamma or normal integrals. 
J. K. Lindsey (1998) studied the parametric regression models to estimate the 
location and dispersion parameters, and compared the performance of nine different 
distributions. Most of the parametric models provided reasonably robust estimates, 
but the recommendation was against using exponential (unreasonable assumption 
of constant hazard over time), log-Student, and log-Cauchy distributions for their 
thick tails. J. C. Lindsey and Ryan (1998) proposed general approaches for interval 
censored data and concluded that parametric approaches can have satisfactory 
performance, especially if the Weibull or log-normal family was chosen, that allows 
for a reasonably wide range of distributional shape. They suggested a piecewise 
exponential distribution could be used to provide more flexibility in modeling as 
long as the number of intervals does not become too large. However, in utilizing a 
piecewise exponential distribution it remains necessary to either visualize the cut 
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points or adopt more rigorous approaches to first estimate the number of cut points 
and identify specific locations of the cut points. As an alternative, adopting the 
Weibull distribution provides reasonable flexibility in modeling monotone hazard 
shapes and performs quite well in comparison to other parametric models. 
Often, as seen with the cardiotoxicity data to be discussed below, with the 
long-term follow-up data the cumulative incidence of the event of interest 
(cardiotoxicity) occurs at a low rate and remains stable over a few years following 
the end of the treatment, and then increases with longer follow-up. The 
identification of the change point is based on human input and visual inspection of 
the data, rather than a rigorous statistical approach. Rai et al. (2013) used a 
piecewise exponential distribution to model cardiotoxicity data. However, this 
approach had three key limitations: (1) it required knowledge of the time point 
when the incidence rate changes, (2) it required knowledge of how many change 
points may be needed, and (3) the incidence rate was assumed to be constant within 
each piece. Therefore, in order to avoid those limitations, the purpose of this study 
is to propose the use of parametric models for modeling such data and, in particular, 
focus on comparing the performance of Weibull model to the approach based on 
piece wise exponential distribution discussed in Rai et al. 
Motivating Example 
A study to investigate cardiotoxic effects of anthracycline exposure during cancer 
treatment was described in Hudson et al. (2007). Specific diagnostic groups 
potentially at risk of cardiotoxicity were identified and recruited from a long-term 
follow-up clinic. The diagnostic group included survivors of childhood leukemia, 
lymphoma, sarcoma, and embryonal tumors who were all treated with 
anthracycline chemotherapy and/or radiation involving the heart, denoted by AR 
(at risk group). The control group comprised of survivors of acute lymphoblastic 
leukemia, Wilms tumor, and germ cell tumors who did not receive any cardiotoxic 
treatment, denoted by NR (not at risk group). The cardiotoxicity can be measured 
by several cardiac measures such as fractional shortening (FS), afterload (AF), QTc 
interval, and ejection fraction; see Hudson et al. (2007) and Krischer et al. (1997). 
Clinically, AF > 74 g/cm2 can be used to identify patients with abnormal AF (AAF). 
Of 278 patients who agreed to participate on the study 223 were designated 
as AR and 55 were designated as NR based on the treatment exposure. At the time 
of survey, data on each individual included demographics, the date of cancer 
diagnosis, time since treatment completion, disease-related variables (type, 
histology, and stage of cancer), treatment-related variables (chemotherapy drugs 
SRIVASTAVA ET AL 
5 
and their doses, irradiation), and outcome-related cardiac measure (AF) and quality 
of life measures (general health, vitality, and physical health; see Cox et al., 2008). 
None of the patients had clinically defined cardiac dysfunction at the time of study 
evaluation. The AAF prevalence was 13.9%. Further details regarding the study 
can be found in Hudson et al. (2007). 
A common practice in estimation of the incidence rates and their confidence 
intervals is to assume the time of follow-up as the onset time and use the familiar 
and widely-used Kaplan-Meier approach (Pui, 2003; Kaplan & Meier, 1958). This 
approach is crude and provides biased estimates of cumulative incidence rates, as 
noted in Odell, Anderson, and D’Agostino (1992) and J. K. Lindsey (1998). In 
addition, there are several issues such as missingness among correlated measures 
of cardiotoxicity and accounting for competing risks (due to death or other 
toxicities) that make the analysis of such data more interesting and challenging. 
Furthermore, some patients who were potentially eligible to be enrolled on the 
study but died were not included in this study. Generalizing the results from the 
selected group of survivors leads to biased results, but alternative approaches such 
as those based on sampling weights could be adopted to obtain relatively unbiased 
estimates. Srivastava, Hudson, Robison, Wu, and Rai (2015) provided a relatively 
detailed account of the statistical issues involved with the design and analysis of 
cohort studies. Thus, the focus here will be on estimating the incidence rates of 
specific toxicities using a robust parametric approach. 
Likelihood-Estimation for General Model 
Hudson et al. (2007) did not include patients who died or had cardiac failure during 
the treatment or during the follow-up. However, this information was available 
from the medical records. Therefore, the general theory for cross-sectional data, 
with indicators of cardiac abnormality and death, and time since treatment to survey 
or death is presented here. 
Following Rai et al (2013), let T denote the observation time (death, cardiac 
failure, or survey) from the date of diagnosis and let U denote the time of cardiac 
abnormality (such as AAF) from the date of diagnosis, which is unknown. Note 
that T and U are measured from the date of cancer diagnosis and are not the current 
age of the patient. 
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Figure 1. An abnormal cardiac measure-death/cardiac failure model involving three 
states: State 1 – patients who are alive with no cardiac abnormality; State 2 – patients 
who are alive with abnormal cardiac measure; and State 3 – (an absorbing state) death 
or cardiac failure patients; the intensity λ1(u), λ2(t), and λ3(t | u) are the transition rates, 
where t is the observation time and u is the time of cardiac abnormality 
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The parameter of interest is 
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the cumulative hazard function, but we observe π(t). 
Let θ, the transition intensities, represent the full parametric vector. To 
construct the likelihood function, we summarize observations into 4 groups: 1) 
Death with No Cardiac Abnormality, 2) Alive with No Cardiac Abnormality, 3) 
Death/Cardiac Failure with Cardiac Abnormality, and 4) Alive with Cardiac 
Abnormality. Furthermore, let the corresponding contributions to the likelihood be 
L1(t)-L4(t) and each individual contributes to only one term in the likelihood, where 
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Note that the likelihood function depends on θ, in addition to the observation time 
and status, but θ is suppressed for notational convenience. 
For parametric modeling, a variety of distributions can be used and the 
intensity functions for a selection of commonly-used parametric distributions are 
provided in Table 1. For the parametric modeling, any of the various parametric 
forms of the intensities, e.g. those listed in Table 1, can be considered, and the 
inference based on likelihood approach can be carried out. However, in light of the 
flexibility provided by the Weibull distribution in modeling monotone intensity 
 
 
Table 1. Some parametric distributions and their corresponding intensity functions 
 
Distribution Density f(t) Intensity function λ(t) 
Exponential -ηtηe  η  
Weibull ( ) ( )α αηα t ηt-1 exp -  αηαt -1  
Log-Normal ( ) ( )( )π t γ ηtγ-1 2 2-1 22 2exp - log  ( ) ( ) t tf 1- log  
Gamma ( ) ( )
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t k
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k
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exp Γ 1- I  
Log-Logistic ( ) ( )  
γ γ
ηγ ηt ηt
-2
-1
1+  ( ) ( )  
γ γ
ηγ ηt ηt
-1
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Note: Ik(s) is the incomplete gamma integral 
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function and the ease of having a relatively simplified form of the likelihood 
function, details of the inference procedure under the Weibull distribution are 
provided. 
Inference under the Weibull Model 
For reporting the results of survival analysis to the practitioners, the focus is often 
on estimating the cumulative incidence at fixed time points, such as 5 or 10 years, 
along with their corresponding 95% confidence intervals. The data observed for 
each patient, at a particular time, consists of observation time T and two status 
indicators: δ (patient’s status) and γ (patient’s event status). Let (tj, δj, γj) be the 
triplet observation for the jth subject; δj = 1 represents if the jth subject had the event 
at time tj, while γj = 1 represents the jth subject’s abnormal value (cardiac 
abnormality) at time tj. 
The intensity functions defined by ( ) 1λ ii i it t
 −=  for i = 1, 2, leads to 
( ) ( )Q exp ii it t= − , and ( ) ( ) ( )1 21 2Q exp expt t t  = − − . The intensity function 
λ3(t | u) can be specified by ( ) 3 1SM3 3 3λ |t u t
  −=  under the assumption of a semi-
Markov process which leads to ( ) ( )( )3 3SM3 3Q | expt u t u = − − , or as 
( ) ( ) 3
1M
3 3 3λ |t u t u

 
−
= −  under the assumption of a Markov process which leads 
to ( ) ( )( )3M3 3Q | expt u t u = − − ; see Kalbfleisch and Lawless (1985) and 
Harezlak, Gao, and Hui (2003). The components of the likelihood contribution are: 
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Then the log-likelihood function is presented as 
 
 
( )
( ) ( ) ( ) ( )
1 1 2 2 3 3
1 2 3 4
1
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log L log L log L log L
n
i i i i i i i i
i
l
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where ai = δi(1 – γi), bi = (1 – δi)(1 – γi), ci = δiγi, and di = (1 – δi)γi are the 
indicators corresponding to observations of type 1 to 4 discussed above. The 
likelihood contributions for rest of the distributions, except exponential, listed in 
Table 1 are cumbersome. This may be another reason why the Weibull distribution 
has been extensively used in practice. 
The maximum likelihood estimates can be obtained by solving the non-linear 
equations obtained by taking the first order derivatives of the likelihood function in 
(3) with respect to the parameters and equating them to 0. The estimates are often 
obtained using the statistical software packages, such as R, that maximize the 
likelihood function in (3) directly or solve the non-linear set of equations, but it 
may be noted that the justification of the asymptotic normality of the estimates is 
for the solutions of the likelihood equations; see Rao (1973). 
Simulation Study 
A simulation study was undertaken to compare the results obtained using piecewise 
exponential and Weibull distributions. The simulations were conducted using 
continuous time scale; see Rai (2008). In the continuous scale model with 
maximum follow-up of 10 years the events can occur at any time between 0 and 10 
years. Two sample sizes (n = 100 and n = 400) were considered. Three different 
design settings were considered for the simulation study. For each scenario the 
estimates of the cumulative incidence (CI) and their standard errors (SEs) were 
obtained based on 5000 replications. 
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Setting I. In this setting, the data were generated from piecewise exponential 
distributions and the estimates of CI (at various time points) were obtained using 
piecewise exponential and Weibull distributions. Specifically, the data were 
generated using a piecewise exponential distribution with two pieces characterized 
by λ11 = λ11(t) and λ12 = λ12(t) of the parameter λ1 = λ1(t) described in Figure 1. The 
set of parameter values of (λ11, λ12) chosen was (0.15, 0.4) to closely resemble the 
simulation parameters considered by Rai et al. (2013). To mimic the situation of 
longer follow-up for the majority of patients, 20% of the patients were expected to 
have shorter follow-up with intensity function λ11 and 80% were expected to have 
longer follow-up with intensity function λ12. For the follow-up time of 10 years the 
change points considered were 2 and 5 years. Once the data was generated from 
piecewise exponential with λ11 = 0.15 and λ12 = 0.4, then the estimates of the CI at 
various time points were estimated using 2-piece exponential and Weibull 
distributions. The results of the comparison are summarized in Table 2. 
 
 
Table 2. Performance of Weibull model for the data generated from piecewise 
exponential distributions with λ11 = 0.15 and λ12 = 0.4 
 
 
Follow-up 
time/Change point 
  Piecewise Exponential  Weibull 
n Time True CI CI (SE)  CI (SE) 
100 10 years/ 1 0.14 0.14 (0.06)  0.14 (0.06) 
 2 year 2 0.26 0.25 (0.11)  0.32 (0.08) 
  3 0.50 0.51 (0.06)  0.50 (0.07) 
  4 0.67 0.68 (0.05)  0.65 (0.06) 
  5 0.78 0.78 (0.05)  0.76 (0.05) 
  6 0.85 0.85 (0.04)  0.85 (0.04) 
  7 0.90 0.90 (0.04)  0.90 (0.04) 
  8 0.93 0.93 (0.03)  0.94 (0.03) 
  9 0.95 0.95 (0.02)  0.96 (0.03) 
  10 0.97 0.97 (0.02)  0.98 (0.02) 
         
 10 years/ 1 0.14 0.14 (0.03)  0.10 (0.05) 
 5 year 2 0.26 0.26 (0.05)  0.24 (0.07) 
  3 0.36 0.36 (0.07)  0.37 (0.07) 
  4 0.45 0.45 (0.08)  0.50 (0.06) 
  5 0.53 0.52 (0.08)  0.61 (0.06) 
  6 0.68 0.69 (0.06)  0.70 (0.05) 
  7 0.79 0.79 (0.06)  0.78 (0.05) 
  8 0.86 0.86 (0.06)  0.84 (0.05) 
  9 0.90 0.90 (0.05)  0.88 (0.05) 
  10 0.94 0.93 (0.04)  0.91 (0.05) 
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Table 2 (continued). 
 
 Follow-up 
time/Change point 
  Piecewise Exponential  Weibull 
n Time True CI CI (SE)  CI (SE) 
400 10 years/ 1 0.14 0.14 (0.03)  0.14 (0.03) 
 2 year 2 0.26 0.26 (0.05)  0.32 (0.04) 
  3 0.50 0.51 (0.03)  0.50 (0.04) 
  4 0.67 0.67 (0.03)  0.65 (0.03) 
  5 0.78 0.78 (0.03)  0.76 (0.03) 
  6 0.85 0.85 (0.02)  0.84 (0.02) 
  7 0.90 0.90 (0.02)  0.90 (0.02) 
  8 0.93 0.93 (0.02)  0.94 (0.02) 
  9 0.95 0.95 (0.01)  0.96 (0.01) 
  10 0.97 0.97 (0.01)  0.98 (0.01) 
         
 10 years/ 1 0.14 0.14 (0.02)  0.10 (0.03) 
 5 year 2 0.26 0.26 (0.03)  0.24 (0.03) 
  3 0.36 0.36 (0.03)  0.38 (0.03) 
  4 0.45 0.45 (0.04)  0.50 (0.03) 
  5 0.53 0.53 (0.04)  0.61 (0.03) 
  6 0.68 0.69 (0.03)  0.70 (0.03) 
  7 0.79 0.79 (0.03)  0.78 (0.03) 
  8 0.86 0.86 (0.03)  0.83 (0.03) 
  9 0.90 0.90 (0.03)  0.88 (0.03) 
  10 0.94 0.93 (0.02)  0.91 (0.02) 
 
 
Setting II. In this setting, the data were generated from two different Weibull 
distributions corresponding to two different scenarios: (A) h(2) = 0.15, h(10) = 0.4 
(slow increasing hazard) and (B) h(2) = 0.15 and h(5) = 0.4 (rapidly increasing 
hazard), where h(t) represents the value taken by the Weibull hazard function at 
time t. For each generated data set the cumulative incidence estimates were 
obtained using Weibull and piecewise exponential distributions with change point 
assumed to be at (a) t – 1, (b) t, and (c) t + 1 years, where t is the time point at which 
h(t) = 0.15 with the follow-up period of 10 years. The results of the comparison are 
summarized in Table 3. 
 
Setting III. In this phase, the data was generated from piecewise exponential 
distributions as in Setting 1. However, since the change point is usually unknown, 
we assumed it to be at (a) t – 1, (b) t, and (c) t + 1 years for the data generated with 
true change points at t = 2 and t = 5 years, respectively. The results of the 
comparison are summarized in Table 4. 
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Table 3. Performance of piecewise exponential (PE) with three assumed change points 
(a), (b), and (c) for the data generated from Weibull distributions corresponding to cases 
A and B with 10 year follow-up 
 
    
Weibull 
 
PE (a) 
 
PE (b) 
 
PE (b) 
n Cases* Time True CI CI (SE)  CI (SE)  CI (SE)  CI (SE) 
100 A 1 0.06 0.06 (0.03)  0.03 (0.06)  0.06 (0.04)  0.09 (0.04) 
  2 0.17 0.17 (0.06)  0.22 (0.04)  0.12 (0.08)  0.17 (0.06) 
  3 0.30 0.30 (0.07)  0.37 (0.05)  0.32 (0.05)  0.24 (0.09) 
  4 0.43 0.43 (0.06)  0.50 (0.05)  0.48 (0.05)  0.44 (0.06) 
  5 0.56 0.56 (0.06)  0.59 (0.05)  0.59 (0.06)  0.58 (0.06) 
  6 0.66 0.67 (0.06)  0.67 (0.05)  0.69 (0.06)  0.69 (0.06) 
  7 0.75 0.76 (0.06)  0.74 (0.05)  0.76 (0.06)  0.76 (0.06) 
  8 0.82 0.83 (0.06)  0.79 (0.05)  0.81 (0.05)  0.82 (0.05) 
  9 0.88 0.88 (0.05)  0.83 (0.05)  0.85 (0.05)  0.86 (0.05) 
   10 0.92 0.92 (0.05)  0.86 (0.04)  0.88 (0.04)  0.90 (0.04) 
               
 B 1 0.03 0.04 (0.02)  0.10 (0.03)  0.04 (0.04)  0.14 (0.03) 
  2 0.13 0.13 (0.05)  0.18 (0.06)  0.07 (0.07)  0.26 (0.05) 
  3 0.28 0.28 (0.07)  0.26 (0.08)  0.35 (0.05)  0.36 (0.06) 
  4 0.46 0.45 (0.07)  0.33 (0.09)  0.55 (0.05)  0.45 (0.07) 
  5 0.62 0.62 (0.06)  0.62 (0.06)  0.68 (0.06)  0.52 (0.08) 
  6 0.76 0.76 (0.06)  0.78 (0.06)  0.78 (0.05)  0.59 (0.08) 
  7 0.86 0.86 (0.05)  0.87 (0.05)  0.84 (0.05)  0.84 (0.06) 
  8 0.92 0.93 (0.04)  0.92 (0.04)  0.89 (0.04)  0.93 (0.04) 
  9 0.96 0.96 (0.02)  0.95 (0.03)  0.92 (0.03)  0.96 (0.03) 
  10 0.98 0.98 (0.02)   0.98 (0.02)   0.94 (0.03)   0.98 (0.02) 
               
400 A 1 0.14 0.06 (0.02)  0.03 (0.03)  0.06 (0.02)  0.09 (0.02) 
  2 0.26 0.17 (0.03)  0.22 (0.02)  0.12 (0.04)  0.17 (0.03) 
  3 0.50 0.30 (0.03)  0.37 (0.02)  0.32 (0.03)  0.24 (0.05) 
  4 0.67 0.43 (0.03)  0.49 (0.03)  0.47 (0.03)  0.43 (0.03) 
  5 0.78 0.56 (0.03)  0.59 (0.03)  0.59 (0.03)  0.58 (0.03) 
  6 0.85 0.67 (0.03)  0.67 (0.03)  0.68 (0.03)  0.68 (0.03) 
  7 0.90 0.75 (0.03)  0.74 (0.03)  0.75 (0.03)  0.76 (0.03) 
  8 0.93 0.82 (0.03)  0.79 (0.03)  0.81 (0.03)  0.82 (0.03) 
  9 0.95 0.88 (0.03)  0.83 (0.02)  0.85 (0.02)  0.87 (0.03) 
  10 0.97 0.92 (0.02)  0.86 (0.02)  0.88 (0.02)  0.90 (0.02) 
               
 B 1 0.14 0.03 (0.01)  0.10 (0.02)  0.04 (0.02)  0.14 (0.01) 
  2 0.26 0.14 (0.03)  0.18 (0.03)  0.07 (0.03)  0.26 (0.02) 
  3 0.36 0.28 (0.04)  0.26 (0.04)  0.35 (0.02)  0.36 (0.03) 
  4 0.45 0.46 (0.04)  0.33 (0.05)  0.54 (0.03)  0.45 (0.04) 
  5 0.53 0.62 (0.03)  0.61 (0.03)  0.68 (0.03)  0.52 (0.04) 
  6 0.68 0.76 (0.03)  0.78 (0.03)  0.77 (0.03)  0.59 (0.04) 
  7 0.79 0.86 (0.02)  0.87 (0.02)  0.84 (0.02)  0.83 (0.03) 
  8 0.86 0.92 (0.02)  0.92 (0.02)  0.89 (0.02)  0.93 (0.02) 
  9 0.90 0.96 (0.01)  0.95 (0.01)  0.92 (0.02)  0.97 (0.01) 
    10 0.94 0.98 (0.01)   0.97 (0.01)   0.94 (0.01)   0.99 (0.01) 
 
Note: *For a description of Weibull distributions and other parameters see Setting II in Simulations Study 
section 
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Table 4. Performance of Weibull model and piecewise exponential PE) distribution for 
varying change points when the data is generated from piecewise exponential 
distributions with λ11 = 0.15 and λ12 = 0.4 
 
 
Follow-up time/ 
Change point 
  
Weibull 
 
PE (a) 
 
PE (b) 
 
PE (b) 
n Time True CI CI (SE)  CI (SE)  CI (SE)  CI (SE) 
100 10 years/ 1 0.06 0.14 (0.06)  0.09 (0.09)  0.14 (0.06)  0.17 (0.05) 
 2 year 2 0.17 0.32 (0.08)  0.36 (0.06)  0.25 (0.11)  0.31 (0.08) 
  3 0.30 0.50 (0.07)  0.55 (0.05)  0.52 (0.06)  0.43 (0.10) 
  4 0.43 0.65 (0.06)  0.68 (0.05)  0.68 (0.05)  0.65 (0.06) 
  5 0.56 0.76 (0.05)  0.78 (0.05)  0.78 (0.05)  0.78 (0.05) 
  6 0.66 0.85 (0.04)  0.84 (0.04)  0.85 (0.04)  0.86 (0.05) 
  7 0.75 0.90 (0.04)  0.89 (0.04)  0.90 (0.04)  0.91 (0.04) 
  8 0.82 0.94 (0.03)  0.92 (0.03)  0.93 (0.03)  0.94 (0.03) 
  9 0.88 0.96 (0.03)  0.94 (0.03)  0.95 (0.02)  0.96 (0.03) 
   10 0.92 0.98 (0.02)   0.96 (0.02)   0.97 (0.02)   0.97 (0.02) 
               
 10 years/ 1 0.03 0.10 (0.05)  0.13 (0.03)  0.14 (0.03)  0.15 (0.03) 
 5 year 2 0.13 0.24 (0.07)  0.25 (0.06)  0.26 (0.05)  0.27 (0.05) 
  3 0.28 0.37 (0.07)  0.34 (0.08)  0.36 (0.07)  0.38 (0.06) 
  4 0.46 0.50 (0.06)  0.43 (0.09)  0.45 (0.08)  0.47 (0.07) 
  5 0.62 0.61 (0.06)  0.60 (0.06)  0.52 (0.08)  0.55 (0.07) 
  6 0.76 0.70 (0.05)  0.71 (0.06)  0.69 (0.06)  0.61 (0.08) 
  7 0.86 0.78 (0.05)  0.79 (0.06)  0.79 (0.06)  0.77 (0.06) 
  8 0.92 0.84 (0.05)  0.85 (0.05)  0.86 (0.06)  0.86 (0.06) 
  9 0.96 0.88 (0.05)  0.89 (0.05)  0.90 (0.05)  0.91 (0.05) 
  10 0.98 0.91 (0.05)   0.92 (0.04)   0.93 (0.04)   0.94 (0.05) 
               
400 10 years/ 1 0.14 0.14 (0.03)  0.10 (0.04)  0.14 (0.03)  0.17 (0.03) 
 2 year 2 0.26 0.32 (0.04)  0.36 (0.03)  0.26 (0.05)  0.32 (0.04) 
  3 0.50 0.50 (0.04)  0.55 (0.03)  0.51 (0.03)  0.44 (0.05) 
  4 0.67 0.65 (0.03)  0.68 (0.03)  0.67 (0.03)  0.64 (0.03) 
  5 0.78 0.76 (0.03)  0.77 (0.02)  0.78 (0.03)  0.77 (0.03) 
  6 0.85 0.84 (0.02)  0.84 (0.02)  0.85 (0.02)  0.85 (0.02) 
  7 0.90 0.90 (0.02)  0.89 (0.02)  0.90 (0.02)  0.90 (0.02) 
  8 0.93 0.94 (0.02)  0.92 (0.02)  0.93 (0.02)  0.94 (0.02) 
  9 0.95 0.96 (0.01)  0.94 (0.01)  0.95 (0.01)  0.96 (0.01) 
  10 0.97 0.98 (0.01)   0.96 (0.01)   0.97 (0.01)   0.97 (0.01) 
               
 10 years/ 1 0.14 0.10 (0.03)  0.13 (0.02)  0.14 (0.02)  0.15 (0.01) 
 5 year 2 0.26 0.24 (0.03)  0.25 (0.03)  0.26 (0.03)  0.27 (0.02) 
  3 0.36 0.38 (0.03)  0.35 (0.04)  0.36 (0.03)  0.38 (0.03) 
  4 0.45 0.50 (0.03)  0.43 (0.04)  0.45 (0.04)  0.47 (0.03) 
  5 0.53 0.61 (0.03)  0.59 (0.03)  0.53 (0.04)  0.55 (0.04) 
  6 0.68 0.70 (0.03)  0.71 (0.03)  0.69 (0.03)  0.62 (0.04) 
  7 0.79 0.78 (0.03)  0.79 (0.03)  0.79 (0.03)  0.77 (0.03) 
  8 0.86 0.83 (0.03)  0.85 (0.03)  0.86 (0.03)  0.86 (0.03) 
  9 0.90 0.88 (0.03)  0.89 (0.02)  0.90 (0.03)  0.91 (0.03) 
    10 0.94 0.91 (0.02)   0.92 (0.02)   0.94 (0.02)   0.96 (0.02) 
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From Table 2, for Setting I, it is clear that when the data are generated from 
piecewise exponential distributions the estimates obtained using piecewise 
exponential are almost unbiased, whereas those based on a Weibull distribution are 
slightly biased with the most bias occurring at the change point. For example, when 
n = 100, the true value of the CI at 2 years is 0.26, whereas the estimates of CI 
corresponding to the piecewise exponential and Weibull distributions are 0.25 and 
0.32, respectively. Similarly, for n = 400, the true value of the CI at 8 years is 0.93 
and the estimates corresponding to piecewise exponential and Weibull are 0.93 and 
0.94, respectively. 
Table 3 summarizes the findings from the simulation experiment for Setting 
II corresponding to sample sizes 100 and 400. This is the situation where the data 
are generated from Weibull distributions and both Weibull and piecewise 
exponential distributions are used to obtain the estimates. For Case B, the rapidly 
rising hazard situation, when the sample size is 100, the true values of the CI 
corresponding to 2, 5, and 10 years are 0.13, 0.62, and 0.98, respectively. The 
corresponding estimates based on Weibull and piecewise exponential with cut point 
at 5 years are 0.13, 0.62, 0.98, and 0.07, 0.68, 0.94, respectively, suggesting that 
the estimates obtained using the exponential distribution are biased. Furthermore, 
if the cut point is not guessed correctly, then these estimates corresponding to cut 
point at 4 or 6 years are 0.18, 0.62, 0.98 and 0.26, 0.52, 0.98, respectively, 
suggesting that the bias could be more pronounced if the cut points are not 
appropriately chosen. The findings are similar for sample size 400. 
The simulation results corresponding to Setting III are summarized in Table 
4. This is the setting where the data are generated from piecewise exponential 
distributions with cut point at t = 2 or t = 5 years and the estimates are obtained 
using piecewise exponential distributions with cut points assumed to be at t – 1, t, 
and t + 1. It is seen that if the cut point is not appropriately chosen then the estimates 
can be significantly biased. For example, when n = 100 and change point is at t = 5, 
then the estimates of the CI at 2, 5, and 10 years from the piecewise exponential 
distribution are 0.25, 0.60, and 0.92 at 4 years, 0.26, 0.52, and 0.93 at 5 years, and 
0.27, 0.55, and 0.94 at 6 years, whereas the true values are 0.26, 0.53, and 0.94, 
respectively. 
Application to a Phase IV Cancer Trial 
The approach based on a semi-Markov assumption proposed above was applied to 
the motivating example and then compared with the non-parametric approach as in 
Sun (2006) and the piecewise exponential proposed by Rai et al. (2013). The study 
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cohort reported in Hudson et al. (2007) did not include the patients who died or had 
already experienced cardiac failure. Rai et al. adopted a piecewise exponential 
distribution of model Cardiac data reported in Hudson et al. and in a subjective 
manner chose the change point to be at 5 years, i.e. tc = 5, and assumed the hazard 
rates to be λ11 for t < tc and λ12 for t ≥ tc. In view of the data collected they obtained 
likelihood solutions for the special case λ2 – λ3. They also examined the usefulness 
of having more than one change point and modeled the data with three piecewise 
exponential distributions. However, the results from the data analysis suggested 
that the group effects were better detected with two piecewise exponential 
distributions compared to three piecewise exponential distributions and was used 
to interpret the findings. Here, the Weibull distribution was used for modeling 
current status data and applied it to Cardiac data. The maximum likelihood 
estimates for the special case of λ2 = λ3 = 0, ai = ci = 0 were obtained using the 
statistical software package R. 
Because Rai et al. (2013) concluded that the piecewise exponential 
distribution provided better results than the interval censored approach, as 
implemented in SAS procedure LIFEREG, the current results were not compared 
with the interval censored approach. Thus, four approaches to compute the 
incidence rates were used and compared. One is the nonparametric approach based 
on Sun (2006). Because there are very few events prior to 5 years, two types of  
 
 
Table 5. Cumulative incidence functions for AAF 
 
   Weibull  Exp-1  Exp-2 
Year Nonparametric CI  CI SE  CI SE  CI SE 
1 0.0000  0.0000 0.0000  0.0160 0.0030  0.0000 0.0000 
2 0.0000  0.0000 0.0000  0.0320 0.0050  0.0000 0.0000 
3 0.0000  0.0000 0.0000  0.0470 0.0080  0.0000 0.0000 
4 0.0000  0.0000 0.0000  0.0630 0.0100  0.0000 0.0000 
5 0.0000  0.0000 0.0000  0.0790 0.0130  0.0000 0.0000 
6 0.0000  0.0620 0.0250  0.0950 0.0160  0.0300 0.0050 
7 0.0590  0.0920 0.0280  0.1100 0.0180  0.0590 0.0100 
8 0.0590  0.1140 0.0320  0.1260 0.0210  0.0890 0.0150 
9 0.1250  0.1330 0.0370  0.1420 0.0230  0.1190 0.0200 
10 0.2000  0.1500 0.0430  0.1580 0.0260  0.1490 0.0250 
11 0.2000  0.1650 0.0480  0.1740 0.0290  0.1780 0.0300 
12 0.2000  0.1790 0.0540  0.1890 0.0310  0.2080 0.0350 
13 0.2000  0.1920 0.0600  0.2050 0.0340  0.2380 0.0400 
14 0.2000  0.2040 0.0660  0.2210 0.0370  0.2670 0.0450 
15 0.2000  0.2150 0.0720  0.2370 0.0390  0.2970 0.0500 
20 0.2500  0.2640 0.0980  0.3160 0.0520  0.4460 0.0750 
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Figure 2. Cumulative incidence function for the four models 
 
 
exponential models were considered: the first with a constant incidence rate 
(denoted by Exp-1), the second with two incidence rates (one up to 5 years as zero 
and the and second beyond 5 years as non-zero positive constant, i.e. piecewise 
exponential with two pieces denoted by Exp-2). The fourth approach is to obtain 
the incidence rates using the proposed Weibull distribution, denoted by Weibull. 
The cumulative incidence functions and their standard errors based on these 
approaches are presented in Table 5 and Figure 2 for AAF. 
The cumulative incidence estimates, along with their 95% confidence 
intervals at specific time points, are provided in Table 6. To avoid the possibility 
of the lower limits of the confidence intervals going below 0, we obtain the 
confidence limits on the log-scale using log-transformation in conjunction with the 
delta method, and then transformed the limits back to obtain the confidence limits 
in original scale, which are also reported in Table 6. 
 
 
Table 6. Cumulative incidence (CI) functions and 95% Confidence Intervals (CIs) at fixed 
time points for Weibull fit to AAF data 
 
Year CI 
Confidence intervals 
based on MLE 
Confidence intervals using 
log-transformation approach 
1 0.000 (0.000, 0.000) (0.000, 0.000) 
3 0.000 (0.000, 0.000) (0.000, 0.000) 
5 0.000 (0.000, 0.000) (0.000, 0.000) 
10 0.150 (0.066, 0.234) (0.086, 0.263) 
15 0.215 (0.074, 0.356) (0.112, 0.414) 
20 0.264 (0.072, 0.456) (0.128, 0.547) 
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The effect of anthracycline exposure on the cumulative incidence of cardiac 
abnormality was evaluated using likelihood ratio test by fitting the proposed models 
for the two groups (AR and NR) independently and then after combing them 
together. The p-values corresponding to piecewise exponential (Exp-2), Weibull, 
and logistic regression are 0.012, 0.044, and 0.065, respectively. The proposed 
approach supports the finding obtained by the piecewise exponential distribution 
but not by logistic regression that those at risk (AR group) have a higher CI of 
developing abnormal afterload (AAF). 
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Conclusions 
The approach based on the Weibull model is better because it is able to capture the 
group effect appropriately without having to make any assumptions about the cut 
point and relaxing the restrictive and unrealistic assumption of constant hazard rates 
for the two pieces. In addition, it is seen that the CI estimates based on the Weibull 
model closely match the ones obtained using the nonparametric approach. Thus, 
the estimates and test based on the Weibull distribution may be capturing the 
underlying hazard pattern appropriately without making restrictive assumptions 
about change point or the hazards being constant within particular time period. 
There will always be situations for which the use of a piecewise exponential 
distribution might be more appropriate (e.g., assumptions underlying the use of 
piecewise exponential distribution would be valid and more appropriate), and in 
those situations more efficient estimates of the parameters and cumulative 
incidence rate can be obtained. However, even in such situations, based on the 
simulation results it is seen that the results obtained from the Weibull distribution 
are reasonable, with most discrepancies observed near the location of the change 
points. Thus, this approach is robust in terms of detecting the group effects, 
providing reasonable fixed term adverse-effect-incidence rates along with 
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confidence intervals. This can be implemented as a routine analysis for similar 
studies at ours and other cancer centers. 
Often, when designing similar studies, questions are asked about required 
sample size for comparing adverse event rates at fixed time-points. The fixed time-
point estimates and confidence intervals obtained using Weibull model along with 
design parameters can be used to justify the required sample size. Another 
extension of this work is to study other types of long term adverse effects such as 
kidney stones in long-term survivors of childhood acute lymphoblastic leukemia, 
Kaste et al, (2009). This can be modelled using a competing risk model or a 
bivariate model that we plan to study further. 
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